Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present China YCT International Group, Inc. (OTC: CYIG).

Full DD Report for CYIG

You must become a subscriber to view this report.



Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-12-140.89990.89990.89990.89994,655
2018-12-130.89990.89990.89990.89992,500
2018-12-120.89990.89990.89990.89993,003
2018-12-110.89990.89990.89990.89993,680
2018-12-100.890.880.890.884,000

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-12-142,0034,65543.0290Short
2018-12-132,5002,500100.0000Short
2018-12-123,0003,00399.9001Short
2018-12-112,6803,68072.8261Short
2018-12-101,0004,00025.0000Cover

* Short Mode

Short Analysis provided by Squeeze Report. Get a complete short report on CYIG.


About China YCT International Group, Inc. (OTC: CYIG)

Logo for China YCT International Group, Inc. (OTC: CYIG)

China YCT International Group CYIG or the Company principally operates through two of its wholly owned subsidiary, Landway Nano Bio Tech Group, Inc. Landway Nano , incorporated in Delaware, and Shandong Spring Pharmaceutical Co., Ltd. Shandong Spring Pharmaceutical , a corporation organized in the People s Republic of China the PRC . Shandong Spring Pharmaceutical is engaged in the business of developing, manufacturing and selling its own medicine made primarily from gingko , development of the acer truncatum bunge planting bases, and distributing health care supplement products manufactured by another company in the PRC.

 

Contact Information

 

 

Current Management

  • Yan Tinghe / CEO
    • Mr. Yan has served as our Chairman and Chief Executive Officer since . Mr. Yan has over twenty years of experience in corporate management within the food and food supplements industries. Mr. Yan founded Shandong Spring Pharmaceuticals, and he has served as its Chairman since January . During the eight years prior to founding Shandong Spring Pharmaceutical, Mr. Yan was employed as Chairman and General Manager of Shandong YCT Bioengineering Co., Ltd., which manufactures a wide variety of food supplements and is currently the exclusive supplier for Shandong Spring Pharmaceutical. During the period from to Mr. Yan served as Executive Vice President of Shishui Sanyin Company, and from to as Factory Director of Beijing Shishui Lianhe Preserved Fruits, both of which were multifacility enterprises in the food industry.
  • Li Chuanmin / CFO
    • Mr. Li has been our Chief Financial Officer since and has been involved with corporate financial management and accounting for over years. Since , he has been employed as Chief Financial Officer of the Company s subsidiary, Shandong Spring Pharmaceutical Co., Ltd. From to Mr. Li was employed as Chief Financial Officer of Shandong Yongchuntang Biotechnology Co., Ltd. From to , Mr. Li was a teacher at the Shandong Finance Institute. From to , he was employed by an accounting firm in Jining City. In , Mr. Li received a diploma from the Shandong Finance Institute.
  • Zecheng Shao / Vice President, IR
    • Mr. Shao has been involved with capital business for over years. Since he has been employed as vice president of the Company s subsidiary, Shandong Spring Pharmaceutical Co., Ltd. From to , Mr. Shao was employed as Minister of Korean Daewoo Group. During the period, he successfully managed, designed and programmed ERP projects and cooperated with the other departments of the company in the past years. All the projects were released on schedule, with high quality that helped the company s business grow. From to , Mr. Shao was a computer engineer at the Shandong Huajin Group. In , Mr. Shao received a diploma from the Shandong Teachers University. In , he received the Super Development Engineer Certificate for PoweBuilder in Sybase Center.
  • Maogang Sun / Gen. Manager
    • Mr. Sun has served as our general manager, deputy general manager, director of pharmaceutical production, quality management, marketing, for Shandong Spring Pharmaceutical Co., Ltd since . Mr. Sun has been engaged in drug manufacturing for years. From to , he worked in the Sishui pharmaceutical factory in Shandong province. From to , he worked in the department of pharmaceutical preparation in a hospital for the Chinese People s Liberation Army Mr. Sun graduated from the Shandong province county people college, where he majored in Chinese Traditional Medicine and engineering.
  • Yan Tinghe / Chairman
    • Mr. Yan has served as our Chairman and Chief Executive Officer since . Mr. Yan has over twenty years of experience in corporate management within the food and food supplements industries. Mr. Yan founded Shandong Spring Pharmaceuticals, and he has served as its Chairman since January . During the eight years prior to founding Shandong Spring Pharmaceutical, Mr. Yan was employed as Chairman and General Manager of Shandong YCT Bioengineering Co., Ltd., which manufactures a wide variety of food supplements and is currently the exclusive supplier for Shandong Spring Pharmaceutical. During the period from to Mr. Yan served as Executive Vice President of Shishui Sanyin Company, and from to as Factory Director of Beijing Shishui Lianhe Preserved Fruits, both of which were multifacility enterprises in the food industry.
  • Robert Fanella / Independent Director, Audit Committee Member, Compensation Committee Member, Nominating Committee Member
    • Mr. Fanella, CPA, was appointed as an independent director, effective April , . During Mr. Fanella s more than years career specializing in corporate finance and accounting, he was responsible for audit and financial service oversight for both private and publicly traded companies. Since , Mr. Fanella has been an independent financial consultant, working on various financial and operational projects for companies in industries such as electronic manufacturing, industrial plating, chemical, and health products.
  • Zhang Jirui / Director
    • Mr. Zhang brings over twenty years of technical training to Shandong Spring Pharmaceutical, where he has been employed as Director since January . During , Mr. Zhang was the Manager of the International Market Department for Shandong YCT Bioengineering Co., Ltd., which manufactures a wide variety of food supplements and is currently the exclusive supplier for Shandong Spring Pharmaceutical. During the years prior to joining Shandong YCT, Mr. Zhang was employed as an Instructor in the Shandong Chemical Engineering Vocational School.
  • Dong Li / Independent Director
    • Mr. Li has successively served as a technician, the director of research and development, the technical director, and deputy general manager at Shandong Yongchuntang Group Co., Ltd Shandong Yongchuntang since November , where he is in charge of the research, development and design of the products, network platform development, and technical service. He is also in charge of the Shandong Yongchuntang s logistics center, research and experimental center, and technical quality center. Previously, Mr. Li served as the server director at Shenzhen Sunshine Technology Co., Ltd from September to September , where he was responsible for the operation and management of the server. Mr. Li received his bachelor degree from Wuhan University of Science and Technology in Wuhan, China.
  • Zhang Wengao / Independent Director, Audit Committee Member, Compensation Committee Member, Nominating Committee Member
    • Mr. Zhang was appointed as an independent director of China YCT International Group on April , . Mr. Zhang has over years of experience in pharmaceutical, Chinese traditional medicine and diagnostic industries. Mr. Zhang is a full time professor of Shandong University of Traditional Chinese Medicine, specializing in clinical treatment via both Chinese and western methods. From to , Professor Zhang was a dean of the research and development department of Shandong University of Traditional Chinese Medicine. Professor Zhang has received various awards within the clinical medicine field, including awards for combining western clinical treatment with traditional Chinese medicine methods, and the th Geneva Invention Silver Award. Professor Zhang has published more than papers concerning the advantages of Chinese traditional medicine in clinical treatment. Among his other engagements, Mr. Zhang is an associate commissioner of the International Chinese Medicine Association and director of the International Chinese Medicine Association Cardiovascular Committee. In , Mr. Zhang received his bachelor degree majoring in Pharmacy from Shandong University of Traditional Chinese Medicine.

Current Share Structure

  • Market Cap: $18,767,176 - 03/16/2018
  • Authorized: 100,000,000 - 02/06/2018
  • Issue and Outstanding: 29,789,168 - 02/06/2018
  • Float: 20,126,227 - 01/22/2018

 


Recent Filings from (OTC: CYIG)

Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: February, 14 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: February, 08 2018
Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: November, 14 2017

 

 


Daily Technical Chart for (OTC: CYIG)

Daily Technical Chart for (OTC: CYIG)


Stay tuned for daily updates and more on (OTC: CYIG)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (OTC: CYIG)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

DD Report
@DDReports

 

 


Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in CYIG is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received no compensation for the publication and circulation of this report. DD Report does not own any shares of CYIG and does not buy, sell, or trade any shares of CYIG. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: https://dd.report/disclaimer/